The Effect of Tamoxifen Dose Increment in Patients With Impaired CYP2D6 Activity.
Welzen ME, Dezentjé VO, van Schaik RH, Colbers AP, Guchelaar HJ, van Erp NP, den Hartigh J, Burger DM, van Laarhoven HW.
Welzen ME, et al. Among authors: van laarhoven hw, van erp np, van schaik rh.
Ther Drug Monit. 2015 Aug;37(4):501-7. doi: 10.1097/FTD.0000000000000195.
Ther Drug Monit. 2015.
PMID: 26192892
Clinical Trial.